Log In
Print
BCIQ
Print
Print this Print this
 

Reditux

  Manage Alerts
Collapse Summary General Information
Company Dr. Reddy's Laboratories Ltd.
DescriptionBiosimilar of rituximab
Molecular Target CD20
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today